IBB Holdings
246 holdings in the fund's latest file; the data source updated it on Oct 8, 2026.
Top 25 Holdings
| # | Holding | Weight | Shares (as reported) | Value (as reported) |
|---|---|---|---|---|
| 1 | GILEAD SCIENCES | 8.24% | 5,844,392 | $858.2M |
| 2 | AMGEN INC | 7.89% | 1,988,326 | $821.3M |
| 3 | VERTEX PHARMACEUTICALS | 7.62% | 1,570,021 | $793.9M |
| 4 | REGENERON PHARMACEUTICALS | 5.34% | 749,729 | $556.4M |
| 5 | MODERNA | 5.21% | 2,763,636 | $543.0M |
| 6 | NATERA | 3.87% | 1,018,489 | $402.9M |
| 7 | ARGENX SE ADR | 3.75% | 420,447 | $390.4M |
| 8 | ILLUMINA INC | 2.93% | 1,139,305 | $305.1M |
| 9 | REVOLUTION MEDICINES | 2.81% | 1,458,447 | $293.0M |
| 10 | BIOGEN | 2.37% | 1,109,438 | $246.5M |
| 11 | BEONE MEDICINES AG | 2.22% | 636,467 | $231.7M |
| 12 | ALNYLAM PHARMACEUTICALS | 2.17% | 1,009,066 | $226.4M |
| 13 | INCYTE CORP | 1.66% | 1,520,187 | $172.5M |
| 14 | UNITED THERAPEUTICS | 1.64% | 313,640 | $170.9M |
| 15 | INSMED | 1.59% | 1,627,414 | $165.6M |
| 16 | GENMAB SPONSORED ADR (GMAB) | 1.47% | 4,191,275 | $153.6M |
| 17 | ROIVANT SCIENCES LTD | 1.32% | 3,965,336 | $137.8M |
| 18 | NEUROCRINE BIOSCIENCES | 1.05% | 760,281 | $109.1M |
| 19 | CHARLES RIVER LABORATORIES INTERNA | 1.03% | 357,164 | $107.3M |
| 20 | ASCENDIS PHARMA | 1.02% | 466,463 | $106.5M |
| 21 | EXELIXIS INC | 1.02% | 1,815,002 | $106.1M |
| 22 | MEDPACE HOLDINGS | 0.99% | 170,007 | $102.7M |
| 23 | HALOZYME THERAPEUTICS | 0.90% | 849,507 | $94.1M |
| 24 | BRIDGEBIO PHARMA | 0.85% | 1,325,024 | $88.1M |
| 25 | BIO TECHNE | 0.82% | 1,180,037 | $85.6M |
Sector Weights
- Healthcare: 100.00%
Country Weights
- United States: 86.23%
- Netherlands: 3.99%
- Switzerland: 2.55%
- Denmark: 2.40%
- United Kingdom: 1.71%
- Germany: 0.67%
- Canada: 0.63%
- Ireland: 0.60%
- France: 0.49%
- China: 0.17%
- Other: 0.13%
- Spain: 0.12%
- Belgium: 0.09%
- Australia: 0.08%
- Italy: 0.07%
- Luxembourg: 0.07%
- Taiwan: 0.00%
Shares, value and weight are as reported in the file, dated by the data source's last update of it (not the date of the positions), never adjusted; a split warning appears only for a split close to or after that date, and its absence does not mean the count is on today's share basis. Weights as the fund reports them. Leveraged and inverse funds list swaps and cash, so weights can be negative or add up past 100.